James R. Kasinger – Insider Trading Activity | DataHeimdall

James R. Kasinger

General Counsel and Secretary at CRISPR Therapeutics AG

CIK: 1674416

10

Total trades

3

Buys

3

Sells

May 29, 2026

Last trade

Date	Stock	Type	Shares	Value	Src
May 29, 2026	CRSPCRISPR Therapeutics AG	Buy	19,500	–
May 29, 2026	CRSPCRISPR Therapeutics AG	Buy	17,000	–
May 29, 2026	CRSPCRISPR Therapeutics AG	Buy	22,000	–
May 28, 2026	CRSPCRISPR Therapeutics AG	Sell	3,786	$211K
May 28, 2026	CRSPCRISPR Therapeutics AG	Option	10,000	–
Dec 24, 2024	CRSPCRISPR Therapeutics AG	Option	13,751	$223K
Dec 28, 2022	CRSPCRISPR Therapeutics AG	Sell	20,366	$831K
Dec 28, 2022	CRSPCRISPR Therapeutics AG	Sell	4,634	$192K
Dec 28, 2022	CRSPCRISPR Therapeutics AG	Option	25,000	$478K
Dec 29, 2020	CRSPCRISPR Therapeutics AG	Option	13,800	$25K